ROBERT KIRK: Open Payments
NPI 1740686369 · AUDUBON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 25 payments from 11 companies in 2025. Trend: 2023 $166 · 2024 $82 · 2025 $632
Food & beverage: $632
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $160 |
| Merz Pharmaceuticals, LLC | 1 | $117 |
| EMD Serono, Inc. | 6 | $97 |
| ANI Pharmaceuticals, Inc. | 4 | $75 |
| ABBVIE INC. | 4 | $65 |
| ACADIA Pharmaceuticals Inc | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
| SCILEX PHARMACEUTICALS INC. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: CAPLYTA, INBRIJA, PURIFIED CORTROPHIN GEL, VRAYLAR, NUPLAZID, INGREZZA, CREXONT, ELYXYB - CELECOXIB.
Industry payments across NJ — which companies pay providers there.
